Hospital
Prime Healthcare Services - Kansas City, LLC
Prime Healthcare Services - Kansas City, LLC was paid $4.44M by Medicaid between Jan 2018 and Nov 2024, across 41 billing codes. Its largest line is 99285, emergency room visit (most serious) — 24% of everything it billed.
33Billing provider infoPRIME HEALTHCARE SERVICES - KANSAS CITY, LLC
KANSAS CITY, MO 64114
KANSAS CITY, MO 64114
33aNPI1528463080assigned 10/27/2014
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.44M
24GClaims55,298
24DCodes billed41
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#38 of 74
Median peer was paid$4.44M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,240 | $909K | |
| 2019 | 3,755 | $801K | |
| 2020 | 3,448 | $419K | |
| 2021 | 2,735 | $103K | |
| 2022 | 15,467 | $697K | |
| 2023 | 21,580 | $1.13M | |
| 2024incomplete | 5,073 | $386K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 24% | 4,882 | 3,941 | $1.06M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 3,979 | 3,436 | $671K |
| X4011 | State-specific procedure code | 11% | 1,561 | 1,314 | $511K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 4,050 | 3,585 | $490K |
| X4014 | 9.9% | 1,708 | 1,324 | $440K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.6% | 9,285 | 7,608 | $382K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.6% | 2,165 | 1,869 | $160K |
| 80053 | Comprehensive metabolic panel | 3.4% | 5,048 | 4,013 | $149K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 1,399 | 1,112 | $120K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.2% | 3,196 | 2,419 | $97K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 2,066 | 1,610 | $71K |
| 81025 | <1% | 348 | 310 | $40K |
29 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,205 | $40K |
| 84484 | <1% | 1,363 | $24K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,056 | $24K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,507 | $16K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 466 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,102 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 532 | $12K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,139 | $12K |
| X4003 | <1% | 51 | $12K | |
| 81003 | <1% | 285 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,386 | $9K |
| 83690 | <1% | 1,124 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 267 | $9K |
| 80076 | <1% | 79 | $7K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 148 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 213 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 109 | $5K |
| 83605 | <1% | 12 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 160 | $4K |
| 81001 | <1% | 714 | $4K | |
| 85027 | <1% | 17 | $3K | |
| J3490 | Unclassified drugs | <1% | 193 | $909.15 |
| 87634 | <1% | 14 | $703.11 | |
| 85610 | <1% | 196 | $302.88 | |
| 85730 | <1% | 129 | $295.58 | |
| 83880 | <1% | 16 | $223.28 | |
| 82550 | <1% | 93 | $215.14 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 19 | $94.96 |
| 82962 | <1% | 16 | $88.11 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.